AUY922 Terminated Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01602627Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies